Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In
  • Log Out

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
  • Log Out
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
Research ArticleOMERACT 9: International Consensus Conference on Outcome Measures in Rheumatology, Kananaskis Village, Alberta, Canada, May 27–31, 2008

Assessing Quality of Sleep in Patients with Rheumatoid Arthritis

GEORGE A. WELLS, TRACY LI, JOHN R. KIRWAN, JOAN PETERSON, DANIEL ALETAHA, MAARTEN BOERS, BARRY BRESNIHAN, MAXIME DOUGADOS, LEANNE IDZERDA, JO NICKLIN, MARIA SUAREZ-ALMAZOR, VIVIAN WELCH and PETER S. TUGWELL
The Journal of Rheumatology September 2009, 36 (9) 2077-2086; DOI: https://doi.org/10.3899/jrheum.090362
GEORGE A. WELLS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: gawells@ottawaheart.ca
TRACY LI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JOHN R. KIRWAN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JOAN PETERSON
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DANIEL ALETAHA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MAARTEN BOERS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
BARRY BRESNIHAN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MAXIME DOUGADOS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
LEANNE IDZERDA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JO NICKLIN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MARIA SUAREZ-ALMAZOR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
VIVIAN WELCH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
PETER S. TUGWELL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
  • eLetters
PreviousNext
Loading

Abstract

We sought to identify instruments assessing sleep quality that measure the domains of sleep applicable to rheumatoid arthritis (RA) patients and are feasible to use and have appropriate reliability, validity, and responsiveness properties. A systematic review of sleep instruments was conducted. In particular, domains related to sleep that were assessed in the instruments were identified and evaluated. Feasibility characteristics and psychometric properties of instruments were reviewed. At OMERACT 9, the preparatory work was described at the plenary session of the Patient Perspective Workshop, and the tasks of 3 breakout groups in ranking and scoring the domains and sleep instruments were outlined. Each breakout group considered different aspects of sleep: sleep domains, feasibility, and psychometric properties. The rapporteur for each breakout group reported back to the plenary on the domains and sleep instruments that achieved the highest rank/score. The systematic review identified 45 sleep instruments of interest. Based on these instruments, 14 domains of sleep were identified. The top ranked domains were: Sleep Adequacy (1), Sleep Maintenance (2), Sleep Initiation (3) and Daytime Functioning (4). The top ranked instruments on feasibility were: Athens Insomnia Scale (2.3), Medical Outcome Study (MOS) Sleep (4.0), Insomnia Severity Index (4.9), and Women’s Health Insomnia Rating Scale (5.5). The highest scored instruments on psychometric properties were: Athens Insomnia Scale (13.6), Sleep Assessment Questionnaire (13), Pittsburgh Sleep Diary (12), and MOS Sleep (11). Sleep domains have been reviewed, and several sleep instruments have been identified. These instruments should be considered for use in planned clinical trials of RA patients to assess their applicability.

  • RHEUMATOID ARTHRITIS
  • SLEEP QUALITY
  • DOMAINS
  • PSYCHOMETRIC PROPERTIES

Patient reported outcomes provide an assessment of a patient’s health, well-being, and treatment from the patient’s perspective. Sleep quality and fatigue have been identified at different OMERACT meetings as important aspects of the health and well-being of patients with arthritis. In particular, at the OMERACT 6 workshop for developing an operational definition of low disease activity state for rheumatoid arthritis (RA), the patient group emphasized fatigue and sleep as important issues in RA1; and at a patient perspective workshop at OMERACT 7 the question of assessing outcomes of treatment for arthritis from the perspective of those who experience the disease themselves was addressed with a particular emphasis placed on fatigue2. The focus here is on sleep in patients with RA. Individuals with a variety of common medical illnesses including arthritis frequently experience sleep disturbances. It is recognized that medical illnesses can adversely affect sleep quality, and that pain, infection, and inflammation can induce symptoms of excessive daytime sleepiness and fatigue3–6. In particular, this is true for patients with RA7–10.

Questionnaires are often the instrument of choice to assess sleep, and in using a particular instrument attention must be given to 3 aspects: the domains of sleep that are evaluated, the feasibility of completing the questionnaire, and the psychometric or measurement properties of the instrument.

First, various domains of sleep have been identified and classification systems for sleep disorders derived. For example, the Diagnostic Classification of Sleep and Arousal Disorders11 grouped sleep disorders into 4 major categories based on the primary symptom: insomnias (initiating and maintaining sleep), excessive sleepiness, sleep-wake schedule and parasomnias (dysfunctions of sleep, sleep stages, or partial arousals). The International Classification of Sleep Disorders12 included insomnias, sleep-related breathing disorders, hypersomnia of central origin not due to circadian rhythm, sleep-related breathing or other causes of disturbed nocturnal sleep disorders, circadian rhythm sleep disorders, parasomnias, and sleep-related movement disorders. Hays and Stewart in The Medical Outcomes Study13 identified domains: initiation, maintenance, quantity, perceived adequacy, somnolence, respiratory impairments, regularity, sleep stage disorders and use of sleep medications.

Second, feasibility relates to the efficiency of the administration of the instrument and the resulting burden of completing the instrument. In particular, this includes both the number of questions and the difficulty in answering the questionnaires based on the questionnaire format, response key, and language level. It is generally known that response rates and validity of the answers are directly related to feasibility14. Ideally, the instrument should have a short administration time, low reading level required, and be easily understood.

Third, the psychometric properties of an instrument of interest refer to the reliability, validity, and sensitivity of the instrument. Reliability is concerned with whether the instrument consistently measures the characteristic of interest, validity relates to whether the instrument measures what it is supposed to measure, and sensitivity to change is concerned with whether the instrument can detect small but clinically important changes. These properties are of particular importance when subjective reports of health status is one of the primary outcomes of the trial.

For properly assessing sleep for patients with RA, 3 key aspects of any sleep instrument need to be considered: the domains, feasibility, and psychometric properties. In terms of the OMERACT filter: truth relates to the domains assessed (content validity) and psychometric properties of validity and reliability; feasibility is directly related to administrative burden and applicability; and discrimination relates to the psychometric property of sensitivity or responsiveness. The first step is a systematic review of the literature for potential sleep instruments that could be used and then attaining consensus on which instruments should be further considered. The objective of our workshop was to identify instruments assessing sleep quality that measure domains of sleep applicable to RA patients and are feasible to use and have appropriate reliability, validity and responsiveness properties.

PREPARING FOR THE PATIENT PERSPECTIVE WORKSHOP ON SLEEP

In preparing for OMERACT 9, the working group met periodically by teleconference and E-mail in addition to in-person meetings at the American College of Rheumatology and European League Against Rheumatism conferences in 2007. A systematic literature review of instruments designed to assess various aspects of sleep was conducted in January 2007, and during 2007 these instruments were evaluated on their response characteristics, psychometric properties, and domains of sleep assessed. The deliverables for OMERACT 9 were to present the results of the systematic literature review on sleep instruments and their truth and feasibility of use in RA. The objective for OMERACT 9 was to select candidate instruments based on truth, discrimination, and feasibility that measure sleep domains of interest.

Systematic review of sleep instruments

In conducting the systematic review the methodology of the Cochrane Collaboration was adhered to and the following steps were undertaken: a comprehensive literature search was conducted (keywords and MeSH terms: sleep, insomnia, sleep disorders, questionnaires, interviews, health surveys, psychometrics, health status, quality of life); citations and articles were selected using predefined criteria by 2 independent reviewers; information on the instruments was extracted from the articles using 2 independent reviewers; characteristics of the instruments were summarized including format properties, number of items, response format, timeline, and psychometric properties (reliability, validity, responsiveness). The literature search included: Medline (1966 to January 2007), PsychINFO (1806 to January 2007), Web-based databases (MAPI Research Institute and Educational Testing Service Test Collection), sleep assessment textbook chapters, bibliographies of sleep research, and review articles. Self-report instruments designed to assess sleep and sleep disorders in adults were selected. Instruments developed to measure sleep disruption secondary to other medical conditions (e.g., Parkinson’s disease, sleep apnea) were excluded, with the exception of chronic pain.

The search resulted in 3751 citations from Medline (1966 to January 2007) and 174 citations from PsychINFO (1806 to January 2007). After applying the selection criteria, 45 instruments were identified that assessed a variety of domains related to sleep (Table 1)15–64. In particular, the domains related to sleep that were assessed in the sleep instruments were identified and summarized, their applicability to chronic diseases, and in particular RA, were evaluated, and the psychometric properties and feasibility aspects of the instruments were reviewed.

View this table:
  • View inline
  • View popup
Table 1.

Sleep instruments ascertained in the systematic review.

The various domains related to sleep that were assessed in the sleep instruments identified in the systematic review were itemized and summarized (Table 2). Fourteen domains were identified and presented at the EULAR 2007 conference. At a meeting of the working group at EULAR 2007, the applicability of these domains to chronic diseases, and in particular RA, was evaluated and confirmed. Also, the response characteristics and psychometric properties of the instruments were identified and summarized and, in preparation for OMERACT 9, a Delphi process reduced the number of instruments for consideration at OMERACT to 15 instruments. Selection of the instruments followed a similar process that would be used at the OMERACT meeting. The response characteristics of the instruments are summarized in Table 3. The number of items typically ranged from 1 to 30 items, the response format was usually a Likert scale (4 or 5 point) or visual analog scale, and the timeline ranged from “recent” to 3 months. Most of the instruments were multidomain, and a summary of their psychometric properties based on the primary report of the instrument is provided in Appendix A.

View this table:
  • View inline
  • View popup
Table 2.

Sleep domains derived from the sleep instruments in the systematic review.

View this table:
  • View inline
  • View popup
Table 3.

Response format of the selected sleep instruments from the systematic review.

BREAKOUT GROUP SESSIONS FOR THE PATIENT PERSPECTIVE WORKSHOP ON SLEEP

At OMERACT 9, the session on sleep was part of the Patient Perspective Workshop that was designed to consider: a Patient Core Set, Sleep, Effective Consumer, and Psychological and Educational Interventions. At the plenary session for the Patient Perspective Workshop, the preparatory work was described and the tasks of 3 breakout groups for sleep were outlined. Each of the breakout groups considered different aspects of sleep: sleep domains, feasibility, and psychometric properties. The rapporteur for each breakout group reported back to the Patient Perspective Workshop on the deliberations of their group. They described the process and any key points raised during the breakout session and provided a summary of the rankings and scorings.

Sleep domains

For this breakout group, a deck of 14 cards was given to each participant. On each card was the identification of a domain related to sleep and a brief description (Table 2), and the participant was to reorder the cards from the most important to the least important domain based on their opinion. Although the domain descriptions were self-explanatory and were in lay language, if needed, the Chair of the breakout group could briefly review the domains. Once the task was completed, each participant returned the card deck ordered from the most important to the least important domain. In reporting back to the Patient Perspective Workshop the following were the 4 highest ranked domains: 1. Sleep Adequacy; 2. Sleep Maintenance; 3. Sleep Initiation; 4. Daytime Functioning.

Feasibility

A package of 15 sheets was given to each participant. On each sheet the identification of the instrument and a summary of the format of the instrument were provided. In addition there was a description of the instrument taken from the primary publication, which could vary from the instrument itself to a listing of the items in the instrument to a simple text description. If needed the Chair of the breakout group could review the “feasibility” component of OMERACT filter of “Truth, Discrimination and Feasibility.” The participant was to reorder the sheets from the most feasible to the least feasible to use based on their opinion. In reporting back to the Patient Perspective Workshop the following were the 4 highest ranked sleep instruments based on feasibility: Athens Insomnia Scale, 2.3; MOS Sleep Measure, 4.0; Insomnia Severity Index, 4.9; Women’s Health Insomnia Rating Scale, 5.5.

Psychometric properties

A package of 15 sheets was given to each participant. On each sheet the identification of the instrument and a summary of the reliability and validity results were provided. The statistics and the details varied by instrument but provided psychometric results given in the primary publication of the instrument. Given the difficulty of the task in evaluating some of the statistical methodology and descriptions of the psychometric properties, the breakout group was divided into 3 subgroups, and each subgroup reviewed 5 instruments. After their review, each subgroup provided opinions on the instruments they reviewed, and the breakout group chairs coordinated a discussion among all the breakout group participants and reached an accord on the scoring of the instruments (with a high score indicating good psychometric properties). The 4 highest scored instruments were: Athens Insomnia Scale, 13.6; Sleep Assessment Questionnaire, 13.0; Pittsburgh Sleep Diary, 12.0; MOS Sleep Measure, 11.0.

CONSENSUS BASED ON SLEEP DOMAINS, FEASIBILITY AND PSYCHOMETRIC PROPERTIES

Based on results from the 3 breakout groups (sleep domains considered most important, highest ranked sleep instruments on feasibility, and the highest scored sleep instruments on psychometric properties), the 4 sleep instruments identified for further consideration were the Athens Insomnia Scale, the MOS Sleep Measure, the Pittsburgh Sleep Diary and the Women’s Health Insomnia Rating Scale (Table 4). Only the Athens Insomnia Scale assessed each of the top 4 sleep domains, and the MOS Sleep Measure and the Pittsburgh Sleep Diary assessed 3 of the domains and partially assessed the fourth domain of daytime functioning. Although the Pittsburgh Sleep Diary scored high on truth, it is difficult to complete and ranked low on feasibility. On the other hand, the Women’s Health Insomnia Rating Scale was easy to complete and so ranked high on feasibility but did not score high on truth. Both the Athens Insomnia Scale and the MOS Sleep Measure scored high on truth and ranked high on feasibility.

View this table:
  • View inline
  • View popup
Table 4.

Sleep instruments identified for further consideration based on a consensus of the scoring of the sleep domains, feasibility and psychometric properties.

In summary, sleep instruments have been evaluated on the domains assessed, feasibility, and psychometric properties. In terms of the OMERACT filter: truth relates to the domains assessed (content validity) and psychometric properties of validity and reliability; feasibility is directly related to administrative burden and applicability; and discrimination relates to the psychometric property of sensitivity or responsiveness.

A number of domains related to sleep have been reviewed, and several sleep instruments have been identified that may be applicable to RA patients, namely: Athens Insomnia Scale, the MOS Sleep Measure, the Pittsburgh Sleep Diary, and the Women’s Health Insomnia Rating Scale. To further evaluate the sleep instruments identified, they should be considered in planned clinical trials of RA patients to assess their applicability. To further establish acceptability and applicability of the domains and the specific instruments, a Delphi exercise involving RA patients to further understand sleep quality from their perspective should be performed.

Appendix A. Reliability and validity of selected sleep instruments from the systematic review

View this table:
  • View inline
  • View popup

Footnotes

  • Supported in part by an unrestricted research grant-in-aid from Bristol-Myers Squibb.

REFERENCES

  1. 1.↵
    1. Wells G,
    2. Anderson J,
    3. Boers M,
    4. et al.,
    MCID/Low Disease Activity State Workshop. Summary, recommendations, and research agenda. J Rheumatol 2003;30:1115–8.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    1. Kirwan J,
    2. Ahlmen M,
    3. de Wit M,
    4. et al.,
    Incorporating the patient perspective into outcome assessment in rheumatoid arthritis — progress at OMERACT 7. J Rheumatol 2005;32:2250–56.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    1. Asplund R
    . Sleep Disorders in the elderly. Drugs Aging 1999;14:91–103.
    OpenUrlCrossRefPubMed
  4. 4.
    1. Moldofsky H
    . Sleep and pain. Sleep Med Rev 2001;5:385–96.
    OpenUrlCrossRefPubMed
  5. 5.
    1. Lashley FR
    . A review of sleep in selected immune and autoimmune disorders. Holistic Nurs Pract 2003;17:65–80.
    OpenUrl
  6. 6.↵
    1. Smith MT,
    2. Wegener ST
    . Sleep disturbances in rheumatic diseases. Association of Rheumatic Health Professionals. Clinical Care in the Rheumatic Diseases, 3rd Ed. Ch 45, Atlanta: American College of Rheumatology; 2006:289–97.
  7. 7.↵
    1. Carr A,
    2. Hewlett S,
    3. Hughes R,
    4. et al.,
    Rheumatology outcomes: The patient’s perspective. J Rheumatol 2003;30:880–3.
    OpenUrlAbstract/FREE Full Text
  8. 8.
    1. Wolfe F,
    2. Michaud K,
    3. Li T
    . Sleep disturbance in patients with rheumatoid arthritis: Evaluation by Medical Outcomes Study (MOS) and visual analog sleep scales. J Rheumatol 2006;33:1942–51.
    OpenUrlAbstract/FREE Full Text
  9. 9.
    1. Abad VC,
    2. Sarinas PS,
    3. Guilleminault C
    . Sleep and rheumatologic disorders. Sleep Med Rev 2008;12:211–28.
    OpenUrlCrossRefPubMed
  10. 10.↵
    1. Drewes AM,
    2. Svendsen L,
    3. Taagholt SJ,
    4. et al.,
    Sleep in rheumatoid arthritis: a comparison with healthy subjects and studies of sleep/wake interactions. Br J Rheumatol 1998;37:71–81.
    OpenUrlAbstract/FREE Full Text
  11. 11.↵
    1. Association of Sleep Disorders Centers, Sleep Disorders Classification Committee,
    2. Roffwarg HP
    . Diagnostic classification of sleep and arousal disorders. Sleep 1979;2:1–137.
    OpenUrlPubMed
  12. 12.↵
    1. American Academy of Sleep Medicine
    . International classification of sleep disorders, 2nd ed. Diagnostic and coding manual. Westchester, IL: American Academy of Sleep Medicine; 2005.
  13. 13.↵
    1. Stewart AL,
    2. Ware JE
    1. Hays RD,
    2. Stewart AL
    . Sleep measures. In: Stewart AL, Ware JE, editors. Measuring functioning and well-being: The Medical Outcomes Study approach. Durham, NC: Duke University Press; 1992:235–59.
  14. 14.↵
    1. Subar A,
    2. Ziegler R,
    3. Thompson F,
    4. et al.,
    5. for the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
    . Is shorter always better? Relative importance of questionnaire length and cognitive ease on response rates and data quality for two dietary questionnaires. Am J Epidemiol 2001;153:404–9.
    OpenUrlAbstract/FREE Full Text
  15. 15.↵
    1. Gillberg M,
    2. Kecklund G,
    3. Akerstedt T
    . Relations between performance and subjective ratings of sleepiness during a night awake. Sleep 1994;17:236–41.
    OpenUrlPubMed
  16. 16.↵
    1. Soldatos CR,
    2. Dikeos DG,
    3. Paparrigopoulos TJ
    . Athens Insomnia Scale: Validation of an instrument based on ICD-10 criteria. J Psychosom Res 2000;48:555–60.
    OpenUrlCrossRefPubMed
  17. 17.↵
    1. Partinen M,
    2. Gislason T
    . Basic Nordic Sleep Questionnaire (BNSQ): A quantitated measure of subjective sleep complaints. J Sleep Res 1995;4 Suppl 1:150–5.
    OpenUrlPubMed
  18. 18.↵
    1. Cote KA,
    2. Ogilvie RD
    . The Brock Sleep and Insomnia Questionnaire: Phase 1. Sleep Res 1993;22:356.
    OpenUrl
  19. 19.↵
    1. Haythornthwaite JA,
    2. Hegel MT,
    3. Kerns RD
    . Development of a sleep diary for chronic pain patients. J Pain Symptom Manage 1991;6:65–72.
    OpenUrlCrossRefPubMed
  20. 20.↵
    1. Sweere Y,
    2. Kerkhof GA,
    3. De Weerd AW,
    4. Kamphuisen HA,
    5. Kemp B,
    6. Schimsheimer RJ
    . The validity of the Dutch Sleep Disorders Questionnaire (SDQ). J Psychosom Res 1998;45:549–55.
    OpenUrlCrossRefPubMed
  21. 21.↵
    1. Morin CM,
    2. Stone J,
    3. Trinkle D,
    4. Mercer J,
    5. Remsberg S
    . Dysfunctional beliefs and attitudes about sleep among older with and without insomnia complaints. Psychol Aging 1993;8:463–7.
    OpenUrlCrossRefPubMed
  22. 22.↵
    1. Johns MW
    . A new method for measuring daytime sleepiness: The Epworth Sleepiness Scale. Sleep 1991;14:540–5.
    OpenUrlPubMed
  23. 23.↵
    1. Johns MW
    . Reliability and factor analysis of the Epworth Sleepiness Scale. Sleep 1992;15:376–81.
    OpenUrlPubMed
  24. 24.↵
    1. Espie CA,
    2. Brooks DN
    . An evaluation of tailored psychological treatment of insomnia. J Behav Ther Exp Psych 1989;20:143–53.
    OpenUrlCrossRef
  25. 25.↵
    1. Weaver TE,
    2. Laizner AM,
    3. Evans LK,
    4. et al.,
    An instrument to measure functional status outcomes for disorders of excessive sleepiness. Sleep 1997;20:835–43.
    OpenUrlPubMed
  26. 26.↵
    1. Harvey KJ,
    2. Espie CA
    . Development and preliminary validation of the Glasgow Content of Thoughts Inventory (GCTI): A new measure for the assessment of pre-sleep cognitive activity. Br J Clin Psych 2004;43:409–20.
    OpenUrlCrossRef
  27. 27.↵
    1. Pavlova M,
    2. Berg O,
    3. Gleason R,
    4. Walker F,
    5. Roberts S,
    6. Regestein Q
    . Self-reported hyperarousal traits among insomnia patients. J Psychosom Res 2001;51:435–41.
    OpenUrlCrossRefPubMed
  28. 28.↵
    1. Bastien CH,
    2. Vallières A,
    3. Morin CM
    . Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Med 2001;2:297–307.
    OpenUrlCrossRefPubMed
  29. 29.↵
    1. Jenkins CD,
    2. Stanton B-A,
    3. Niemcrym SJ,
    4. Rose RM
    . A scale for the estimation of sleep problems in clinical research. J Clin Epidemiol 1988;41:313–21.
    OpenUrlCrossRefPubMed
  30. 30.↵
    1. Keklund G,
    2. Akerstedt T
    . Objective components of individual differences in subjective sleep quality. J Sleep Res 1997;6:217–20.
    OpenUrlCrossRefPubMed
  31. 31.↵
    1. Akerstedt T,
    2. Gillberg M
    . Subjective and Objective Sleepiness in the Active Individual. Int J Neurosci 1990;52:29–37.
    OpenUrlPubMed
  32. 32.↵
    1. Parrott AC,
    2. Hindmarch I
    . The Leeds Sleep Evaluation Questionnaire in psychopharmacological investigations — a review. Psychopharmacology 1980;71:173–9.
    OpenUrlCrossRefPubMed
  33. 33.↵
    1. Hays RD,
    2. Martin SA,
    3. Sesti AM,
    4. Spritzer KL
    . Psychometric properties of the Medical Outcomes Study Sleep Measure. Sleep Med 2005;6:41–4.
    OpenUrlCrossRefPubMed
  34. 34.↵
    1. Maldonado CC,
    2. Bentley AJ,
    3. Mitchell D
    . A pictorial sleepiness scale based on cartoon faces. 2004;27:541–8.
  35. 35.↵
    1. Monk TH,
    2. Reynolds CF,
    3. Kupfer DJ,
    4. et al.,
    The Pittsburgh Sleep Diary. Sleep Res 1994;3:111–20.
    OpenUrlCrossRef
  36. 36.↵
    1. Buysse DJ,
    2. Reynolds CF,
    3. Monk TH,
    4. Berman SR,
    5. Kupfer DJ
    , The Pittsburgh Sleep Quality Index: A New Instrument for Psychiatric Practice and Research. Psychiatry Res 1989;28:193–213.
    OpenUrlCrossRefPubMed
  37. 37.↵
    1. Webb WB,
    2. Bonnet M,
    3. Blume G
    . A post-sleep inventory. Percept Motor skills 1976;43:987–93.
    OpenUrl
  38. 38.↵
    1. Nicassio PM,
    2. Mendlowitz DR,
    3. Fussell JJ,
    4. Petras L
    . The phenomenology of the pre-sleep state: the development of the Pre-Sleep Arousal Scale. Behav Res Ther 1985;23:263–71.
    OpenUrlCrossRefPubMed
  39. 39.↵
    1. Pires De Souza JC
    . Quality of life and insomnia in university psychology students. Human Psychopharmacology 1996;11:169–84.
    OpenUrlCrossRef
  40. 40.↵
    1. Rombaut N,
    2. Maillard F,
    3. Kelly F,
    4. Hindmarch I
    . The Quality of Life of Insomniacs Questionnaire (QOLI). Med Sci Res 1990;18:845–7.
    OpenUrl
  41. 41.↵
    1. Violani C,
    2. Lucidi F,
    3. Robusto E,
    4. Devoto A,
    5. Zucconi M,
    6. Ferini Strambi L
    . The assessment of daytime sleep propensity: a comparison between the Epworth Sleepiness Scale and a newly developed Resistance to Sleepiness Scale. Clin Neurophysiol 2003;114:1027–33.
    OpenUrlCrossRefPubMed
  42. 42.↵
    1. Van Knippenberg FC,
    2. Passchier J,
    3. Heystech D,
    4. et al.,
    The Rotterdam Daytime Sleepiness Scale: a new daytime sleepiness scale. Psychol Rep 1995;76:83–7.
    OpenUrlPubMed
  43. 43.↵
    1. Spoormaker VI,
    2. Verbeek I,
    3. van den Bout J,
    4. Klip EC
    . Initial Validation of the SLEEP-50 Questionnaire. Behav Sleep Med 2005;3:227–46.
    OpenUrlCrossRefPubMed
  44. 44.↵
    1. Cesta A,
    2. Moldofsky H,
    3. Sammut C
    . The University of Toronto Sleep Assessment Questionnaire (SAQ). Sleep Res 1996;25:486.
    OpenUrl
  45. 45.↵
    1. Cesta A,
    2. Moldofsky H,
    3. Sammut C
    . The University of Toronto Sleep Assessment Questionnaire (SAQ). Sleep Res 1997;26:646.
    OpenUrl
  46. 46.↵
    1. Kazarian SS,
    2. Howe MG,
    3. Csapo KG
    . Development of the Sleep Behavior Self-Rating Scale. Behav Ther 1979;10:412–7.
    OpenUrlCrossRef
  47. 47.↵
    1. Adan A,
    2. Fabbri M,
    3. Vincenzo N,
    4. Prat G
    . Sleep Beliefs Scale (SBS) and circadian typology. J Sleep Res 2006;15:125–32.
    OpenUrlPubMed
  48. 48.↵
    1. Douglass AB,
    2. Bornstein R,
    3. Nino-Murcia G,
    4. et al.,
    The Sleep Disorders Questionnaire I: creation and multivariate structure of SDQ. Sleep 1994;17:160–7.
    OpenUrlPubMed
  49. 49.↵
    1. Coyle K,
    2. Watts FN
    . The factorial structure of sleep dissatisfaction. Behav Res Ther 1991;29:513–20.
    OpenUrlCrossRefPubMed
  50. 50.↵
    1. Zammit GK
    . Subjective ratings of the characteristics and sequelae of good and poor sleep in normals. J Clin Psych 1988;44:123–30.
    OpenUrl
  51. 51.↵
    1. Parrott AC,
    2. Hindmarch I
    . Factor analysis of a sleep evaluation questionnaire. Psychol Med 1978;8:325–9.
    OpenUrlPubMed
  52. 52.↵
    1. Mastin DF,
    2. Bryson J,
    3. Corwyn R
    . Assessment of sleep hygiene using the Sleep Hygiene Index. J Behav Med 2006;29:223–7.
    OpenUrlCrossRefPubMed
  53. 53.↵
    1. Neitzert Semler C,
    2. Harvey AG
    . Monitoring for sleep-related threat: a pilot study of the Sleep Associated Monitoring Index (SAMI). Psychosom Med 2004;66:242–50.
    OpenUrlAbstract/FREE Full Text
  54. 54.↵
    1. Yi H,
    2. Shin K,
    3. Shin C
    . Development of the Sleep Quality Scale. J Sleep Res 2006;15:309–16.
    OpenUrlCrossRefPubMed
  55. 55.↵
    1. Domino G,
    2. Blair G,
    3. Bridges A
    . Subjective Assessment of Sleep by Sleep Questionnaire. Percept Mot Skills 1984;59:163–170.
    OpenUrlPubMed
  56. 56.↵
    1. Lacks P
    . Behavioral Treatment of Persistent Insomnia. Elmsford, New York: Pergamon Press; 1987.
  57. 57.↵
    1. Monk TH,
    2. Buysse DJ,
    3. Kennedy KS,
    4. Potts JM,
    5. DeGrazia JM,
    6. Miewald JM
    . Measuring Sleep Habits Without Using a Diary: The Sleep Timing Questionnaire. Sleep 2003;26:208–12.
    OpenUrlPubMed
  58. 58.↵
    1. Rosenthal L,
    2. Roehrs TA,
    3. Roth T
    . The Sleep-Wake Activity Inventory: A self-report measure of daytime sleepiness. Biol Psychiatry 1993;34:810–20.
    OpenUrlCrossRefPubMed
  59. 59.↵
    1. Hoddes E,
    2. Zarcone V,
    3. Smythe H,
    4. Phillips R,
    5. Dement WC
    , Quantification of sleepiness: a new approach. Psychophysiology 1973;10:431–6.
    OpenUrlCrossRefPubMed
  60. 60.↵
    1. Ellis BW,
    2. Johns MW,
    3. Lancaster R,
    4. Raptopoulos P,
    5. Angelopoulos N,
    6. Priest RG
    . The St. Mary’s Hospital Sleep Questionnaire: A study of reliability. Sleep 1981;4:93–7.
    OpenUrlPubMed
  61. 61.↵
    1. Leigh TJ,
    2. Bird HA,
    3. Hindmarch I,
    4. Constable PD,
    5. Wright V
    . Factor analysis of the St. Mary’s Hospital Sleep Questionnaire. Sleep 1988;11:448–53.
    OpenUrlPubMed
  62. 62.↵
    1. Snyder-Halpern R,
    2. Verran JA
    . Instrumentation to describe subjective sleep characteristics in healthy subjects. Res Nurs Health 1987;10:155–63.
    OpenUrlPubMed
  63. 63.↵
    1. Levine DW,
    2. Kripke DF,
    3. Kaplan RM,
    4. et al.,
    Reliability and validity of the Women’s Health Initiative Insomnia Rating Scale. Psychol Assess 2003;15:137–48.
    OpenUrlCrossRefPubMed
  64. 64.↵
    1. Levine DW,
    2. Kaplan RM,
    3. Kripke DF,
    4. Bowen DJ,
    5. Naughton MJ,
    6. Shumaker SA
    . Factor structure and measurement invariance of the Women’s Health Initiative Insomnia Rating Scale. Psychol Assess 2004;15:123–36.
    OpenUrlCrossRef
View Abstract
PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 36, Issue 9
1 Sep 2009
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Assessing Quality of Sleep in Patients with Rheumatoid Arthritis
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Assessing Quality of Sleep in Patients with Rheumatoid Arthritis
GEORGE A. WELLS, TRACY LI, JOHN R. KIRWAN, JOAN PETERSON, DANIEL ALETAHA, MAARTEN BOERS, BARRY BRESNIHAN, MAXIME DOUGADOS, LEANNE IDZERDA, JO NICKLIN, MARIA SUAREZ-ALMAZOR, VIVIAN WELCH, PETER S. TUGWELL
The Journal of Rheumatology Sep 2009, 36 (9) 2077-2086; DOI: 10.3899/jrheum.090362

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Assessing Quality of Sleep in Patients with Rheumatoid Arthritis
GEORGE A. WELLS, TRACY LI, JOHN R. KIRWAN, JOAN PETERSON, DANIEL ALETAHA, MAARTEN BOERS, BARRY BRESNIHAN, MAXIME DOUGADOS, LEANNE IDZERDA, JO NICKLIN, MARIA SUAREZ-ALMAZOR, VIVIAN WELCH, PETER S. TUGWELL
The Journal of Rheumatology Sep 2009, 36 (9) 2077-2086; DOI: 10.3899/jrheum.090362
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • PREPARING FOR THE PATIENT PERSPECTIVE WORKSHOP ON SLEEP
    • BREAKOUT GROUP SESSIONS FOR THE PATIENT PERSPECTIVE WORKSHOP ON SLEEP
    • CONSENSUS BASED ON SLEEP DOMAINS, FEASIBILITY AND PSYCHOMETRIC PROPERTIES
    • Appendix A. Reliability and validity of selected sleep instruments from the systematic review
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
  • eLetters

Related Articles

Cited By...

More in this TOC Section

  • Progress in Measurement Instruments for Acute and Chronic Gout Studies
  • Measures of Response in Clinical Trials of Systemic Sclerosis: The Combined Response Index for Systemic Sclerosis (CRISS) and Outcome Measures in Pulmonary Arterial Hypertension Related to Systemic Sclerosis (EPOSS)
  • Progress Towards a Core Set of Outcome Measures in Small-vessel Vasculitis. Report from OMERACT 9
Show more OMERACT 9: International Consensus Conference on Outcome Measures in Rheumatology, Kananaskis Village, Alberta, Canada, May 27–31, 2008

Similar Articles

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2022 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire